Tenax CFO Thomas R. Staab II buys USD 10,982.63 in common shares
TENX•CFO adds to Tenax Therapeutics stake
- Tenax Therapeutics CFO Thomas R. Staab II bought 5,675 common shares at USD 1.94, raising his direct stake to 15,675 shares.
- Staab also reported beneficial ownership of 450,000 stock options with an exercise price of USD 11.95.




